Pain evaluation in children and adolescents with sickle cell disease

Authors

  • Meire Aparecida Tostes
  • Josefina Aparecida Pellegrini Braga
  • Claudio Arnaldo Len
  • Maria Odete Esteves Hilário

Keywords:

Hemoglobin SC disease, Pain, Pain measurement, Questionnaires

Abstract

Objective
To eva[uate the frequency. intensity. location and duration of pain in patlents with síckle cell disease. monitored by the Pediatríc Hematology Unit, Department of Pediatrics af Universidade Federal de São Paulo (São Paulo - Brazil).
Methods
Patients with sickle cell disease were evaluated by means of home-based questionnaires given to the patients and parents/caregivers. For pain measurement
we used three scales: analog visual, faces and verbal.
Results
The study group comprised 23 patients (aged 8-15 years). Thirteen patients (56.5%) were male; 16 patients (70.0%) presented sickle cell anemia, 4 (17.0%)
had sickle cell SC disease and 3 (13.O%) suffered from sickle cell disease Beta*thalassemia. We observed pain related to sickle cell disease in 12 patients (52.2%). The average intensity of the worst pain (at home) and monthly average pain were 5.4 and 5.0 respectively; 9/12 patients (75.0%) presented pain in more than one location per event; 100.O% reported using pharmacological measures at home to alleviate the pain; pain had a greater impact on school activities and
leisure, The correlation. between the pain reported by the 23 patients and that reported by their respective caregivers, showed that the caregivers score was
significantly higher (Wilcoxon test, p=0.013), but we did not observe significant dívergence between them using the Kappa test (p=0.007).
Conclusion
Patients with sickle cell disease present moderate pain intensity between medical visits, with a negative impact on their daily activities.

Downloads

Download data is not yet available.

References

Dover GJ, Platt OS. Sickle cell disease. In: Nathan DG. Orkin SH. Nathan and Oski’s hematology of infancy and childhood. 5th ed. Philadelphia: W.B. Saunders; 1998. p.762-95.

Zago MA. Considerações gerais. In: Manual de diagnóstico e tratamento de doenças falciformes. Brasília: ANVISA; 2002. p.7-11.

Ramalho AS. As Hemoglobinopatias hereditárias: um problema de saúde pública no Brasil. Ribeirão Preto: Sociedade Brasileira de Genética; 1986.

Ramalho AS, Magna LA, Paiva e Silva RB. A Portaria nº 822/01 do Ministério da Saúde e as peculiaridades das hemoglobinopatias em saúde pública no Brasil. Cad Saúde Pública. 2003; 19(4):1195-9.

Erush K, Ware R, Kinney T, Emergency department visits by children with sickle hemoglobinopathies: factors associated with hospital admission. Pediatr Ernerg Care. 1995; 11(1):9-12.

Benjamin I J. Nature and treatment of the acute painful episode in sickle cell disease. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL. Disorders of hemoglobin: genetics. pathophysiology, and clinical management. New York: Cambridge University Press; 2001. p.671-710.

Shapiro SB. Tratamento da dor na anemia falciforme. In: Schechter NL. Dor aguda em crianças. Clin Pediatr Arn Norte. 1989; 36(6):1085-98.

Grunau RVE, Craig KD, Pain expression in neonates: facial action and cry. Pain. 1987; 28(3):395-410.

Chambers CT, Reid GJ, McGrath PJ, Finley GA. Development and preliminary validation of a postoperative pain measure for parents. Pain. 1996, 68(2-3):307-13.

McGrath PJ, Finley GA. A Medição da dor. In: A dor na infância. Anais Nestlé. 2000; 59:14-22.

Beyer JE, Wells N. Avaliação da dor em crianças. Pediatr Clin North Am. 1989; 36(6):881-99.

Chapman CR, Syrjala KL. Measurement of pain. In Bonica JJ, Loeser JD, Chapman CR, Wilbert E. The Management of pain. 2nd ed. Philadephia: Lea & Febiger; 1990. p.580-94.

McGrath PF, Unruh AM. Measurement and assessment of paediatric. In: Wall PD, Melzack R. Textbook of pain. 3th ed. London: Churchill Livingstone; 1994. p.303-13.

Bieri D, Reeve RA, Champion GD, Addicoat L, Ziegler JB. The faces pain scale for the selfassessment of the severity of pain experienced by children: development, initial validation, and preliminary investigation for ratio scale properties. Pain. 1990; 41 (2):139-50.

Alvim RC, Viana MB, Franklin HM. Paula MJ. Brito AC, Oliveira TF, et al. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease. Acta Haematol 2005: 113(4):228-33.

Remington RD, Schork MA. Statistics with applications to biological and health sciences. Englewood (NJ) Prentice-Hal1; 1970.

Landis JR, Kock GG. The measurement of observer agreement for categorical data. Biornetrics. 1977; 33(1): 159-74.

Siegel S, Castellan JR. Nonparametric.- statistics. New York: MacGrawHil1; 1988.

Shapiro BS, Dinges DF, Orne EC, Bauer N, Reilly L, Whitehouse WG, et al. Home management of sickle cell related pain in children and adofescents: natural history and impact on school attendance. Pain. 1995, 61 (1): 139-44.

Fuggle P, Shand PAX, Gill LJ, Davies SC. Pain, quality of life, and coping in sickle cell disease. Arch Dis rhild 1996; 75(3):199-203.

Maikler VE, Broome ME, Bailey P, Lea G. Childrens’ and adolescents’ use of diaries for sickle cell pain Soc J Pediatr Nurs, 2001; 6(4):161-9.

Graumlich SE, Powers SW, Byars KC, Schwarber LA, Mitchell MJ, Kalinyak KA. Multidirnensional assessment of pain in pediatric sickle cell disease. J Pediatr Psychol. 2001; 26(4):203-14.

Published

2008-12-31

How to Cite

Tostes, M. A., Braga, J. A. P., Len, C. A., & Hilário, M. O. E. (2008). Pain evaluation in children and adolescents with sickle cell disease. Revista De Ciências Médicas, 17(3/6). Retrieved from https://seer.sis.puc-campinas.edu.br/cienciasmedicas/article/view/751

Issue

Section

Artigos Originais